期刊文献+

司来吉兰贴片的分析方法研究

STUDY ON ANALYTICAL METHODS OF SELEGILINE TRANSDERMAL PATCHES
下载PDF
导出
摘要 本文主要研究了司来吉兰贴片药物含量的测定分析方法。先制备司来吉兰贴片,然后进行方法学论证。结果发现高效液相色谱法准确度高、干扰小,而且精密度、回收率和检测限高。因此高效液相色谱法是测定司来吉兰药物含量的一种有效的方法。 The objective of the paper is to study analytical methods of selegiline transdermal patches. The selegiline transdermal patches are prepared, then its analytical methods are studied. The results show HPLC method is accurate, reliable and simple. So HPLC is suitable for the determination of selegiline in patches.
出处 《南阳理工学院学报》 2010年第2期61-64,共4页 Journal of Nanyang Institute of Technology
关键词 司来吉兰 贴片 高效液相色谱法 Selegiline Patches HPLC
  • 相关文献

参考文献6

二级参考文献36

  • 1边佳明,赵维娟,许景峰.国外经皮给药系统的研究进展[J].中国药房,2005,16(14):1112-1114. 被引量:21
  • 2赵鹏,张本恕,肖颖,孔屏,孙峰.盐酸司来吉兰治疗早期帕金森病的疗效观察[J].临床神经病学杂志,2005,18(4):306-307. 被引量:9
  • 3Ebadi M,Sharma S,Shavali S,et al.Neuroprotective actions of selegiline[J].J Neurosci Res,2002, 67:285.
  • 4Larsen JP,Boas J,Erdal JE.Does selegiline modify the progression of early Parkinsons disease? Results from a five-year study. The Norwegian-Danish Study Group[J].Eur J Neurol,1999,6:539.
  • 5Palhagen S,Heinonen EH,Hagglund J,et al.Selegiline delays the onset of disability in de novo parkinsonian patients.Swedish Parkinson Study Group[J].Neurology,1998,51:520.
  • 6LeWitt P,Oakes D,Cui L.The need for levodopa as an end point of Parkinsons disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group[J].Mov Disord,1997,12:183.
  • 7Heinonen EH,Myllyla V.Safety of selegiline (deprenyl) in the treatment of Parkinsons disease[J].Drug Saf,1998,19:11.
  • 8Bhattacharya KF,Nouri S,Olanow CW,et al.Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension[J].Parkinsonism Relat Disord,2003,9:221.
  • 9Churchyard A, Mathias CJ, Boonkongchuen P, et al. Autonomic effects of selegiline:possible cardiovascular toxicity in Parkinsons disease[J].J Neurol Neurosurg Psychiatry,1997,63:228.
  • 10Langer R.Transdermal drug delivery:past progress,current status, and future prospects [ J ] . Adv Drug Del Rev, 2004, 56(5): 557.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部